Inventor · disambiguated record
Andrew Mccreary
Also filed as: MCCREARY ANDREW · MCCREARY ANDREW C
12 granted patents·5 pending applications·42 citations·filing 2002–2010
87Inventor score
Top patents by PatentIndex Score
17 records- 0179US7786126B2Combination preparations comprising SLV308 and a dopamine agonistSOLVAY PHARM BV·Filed 2007·Granted Aug 31, 2010·1 cites·19 claims
- 0279US7319110B21H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Jan 15, 2008·14 cites·4 claims
- 0378US6828325B2PhenylpiperazinesSOLVAY PHARM BV·Filed 2002·Granted Dec 7, 2004·13 cites·5 claims
- 0469US7244734B2Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with NK1 antagonistic activitySOLVAY PHARM BV·Filed 2004·Granted Jul 17, 2007·6 cites·8 claims
- 0568US8101619B2Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibitionFEENSTRA ROELOF W·Filed 2005·Granted Jan 24, 2012·2 cites·8 claims
- 0665US7750013B2N-oxides as prodrugs of piperazine and piperidine derivativesSOLVAY PHARM BV·Filed 2006·Granted Jul 6, 2010·1 cites·8 claims
- 0763US7202238B2Diazabicyclo alkane derivatives with NK1 antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Apr 10, 2007·4 cites·6 claims
- 0857US7342032B2Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activitySOLVAY PHARMACEUTICALS INC·Filed 2003·Granted Mar 11, 2008·1 cites·9 claims
- 0956US7915262B2Combination preparations comprising SLV308 and a dopamine agonistSOLVAY PHARM BV·Filed 2010·Granted Mar 29, 2011·0 cites·2 claims
- 1050US8106056B2Combination preparations comprising bifeprunox and a dopamine agonistMCCREARY ANDREW C·Filed 2007·Granted Jan 31, 2012·0 cites·13 claims
- 1144US2007219214A1Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparationSOLVAY PHARM GMBH·Filed 2007·Application pending·0 cites
- 1242US2007142397A2Phenypiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibitionSOLVAY PHARMECEUTICALS B V·Filed 2005·Application pending·0 cites
- 1339US2005038015A1Partial dopamine-D 2 receptor agonist plus serotonin and/oder noradrenaline inhibitor activityFiled 2003·Application pending·0 cites
- 1438US7094779B2Piperazine oxime dervatives having NK-1 receptor antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted Aug 22, 2006·0 cites·7 claims
- 1538US2005215567A11-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of painSOLVAY PHARM BV·Filed 2005·Application pending·0 cites
- 1638US2005215551A11-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disordersSOLVAY PHARM BV·Filed 2005·Application pending·0 cites
- 1737US8575210B2Use of indole derivatives as NURR-1 activators for treating parkinson's diseaseBOUBIA BENAISSA·Filed 2009·Granted Nov 5, 2013·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Andrew Mccreary files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →